Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples